JP2022525099A5 - - Google Patents
Info
- Publication number
- JP2022525099A5 JP2022525099A5 JP2021554674A JP2021554674A JP2022525099A5 JP 2022525099 A5 JP2022525099 A5 JP 2022525099A5 JP 2021554674 A JP2021554674 A JP 2021554674A JP 2021554674 A JP2021554674 A JP 2021554674A JP 2022525099 A5 JP2022525099 A5 JP 2022525099A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- polynucleotide
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962816746P | 2019-03-11 | 2019-03-11 | |
| US62/816,746 | 2019-03-11 | ||
| PCT/US2020/021916 WO2020185796A1 (en) | 2019-03-11 | 2020-03-10 | High avidity wt1 t cell receptors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525099A JP2022525099A (ja) | 2022-05-11 |
| JP2022525099A5 true JP2022525099A5 (cg-RX-API-DMAC7.html) | 2023-03-17 |
| JP7611844B2 JP7611844B2 (ja) | 2025-01-10 |
Family
ID=70155376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554674A Active JP7611844B2 (ja) | 2019-03-11 | 2020-03-10 | 高アビディティwt1t細胞受容体とその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12448430B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3938386A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7611844B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210138043A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113784978B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020237043A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021017703A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3132845A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202192252A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL286202A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021010837A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202109745PA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020185796A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3551221T2 (ro) | 2016-12-08 | 2022-04-30 | Immatics Biotechnologies Gmbh | Noi receptori de celule T și imunoterapie cu utilizarea acestora |
| CR20230295A (es) * | 2020-12-31 | 2023-07-27 | Immatics Us Inc | Polipéptidos cd8, composiciones y métodos de uso de estos |
| CN120112559A (zh) * | 2022-10-28 | 2025-06-06 | 百奥赛图(北京)医药科技股份有限公司 | 抗wt1/hla抗体及其应用 |
| WO2025029648A1 (en) * | 2023-07-28 | 2025-02-06 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting loxhd1-associated disease |
| WO2025245169A1 (en) | 2024-05-21 | 2025-11-27 | Fred Hutchinson Cancer Center | Immunotherapy cells equipped with a collagen-targeting payload |
| WO2026125718A1 (en) * | 2024-12-13 | 2026-06-18 | Immunoscape Pte. Ltd. | Human t cell receptors and uses thereof |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| AU4932199A (en) | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
| US8206965B2 (en) | 2002-03-15 | 2012-06-26 | Cellectis S.A. | Hybrid and single chain meganucleases and use thereof |
| EP1550453B1 (en) | 2002-09-12 | 2015-05-27 | International Institute of Cancer Immunology, Inc. | Cancer antigen peptide preparation |
| US20060206949A1 (en) | 2003-01-28 | 2006-09-14 | Sylvain Arnould | Custom-made meganuclease and use thereof |
| GB0328363D0 (en) | 2003-12-06 | 2004-01-14 | Imp College Innovations Ltd | Therapeutically useful molecules |
| PT1731605E (pt) | 2004-03-31 | 2010-04-14 | Int Inst Cancer Immunology Inc | Péptidos antigénicos de cancro derivados de wt1 |
| WO2006076678A2 (en) | 2005-01-13 | 2006-07-20 | The Johns Hopkins University | Prostate stem cell antigen vaccines and uses thereof |
| DK3246403T3 (da) | 2005-10-18 | 2020-10-26 | Prec Biosciences | Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| EP2210903A1 (en) | 2009-01-21 | 2010-07-28 | Monoclonal Antibodies Therapeutics | Anti-CD160 monoclonal antibodies and uses thereof |
| EP2258719A1 (en) | 2009-05-19 | 2010-12-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Multiple target T cell receptor |
| AU2011256838B2 (en) | 2010-05-17 | 2014-10-09 | Sangamo Therapeutics, Inc. | Novel DNA-binding proteins and uses thereof |
| US9676854B2 (en) | 2011-08-15 | 2017-06-13 | Medimmune, Llc | Anti-B7-H4 antibodies and their uses |
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| EP3064585B1 (en) | 2012-12-12 | 2020-02-05 | The Broad Institute, Inc. | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
| AU2013361275B2 (en) | 2012-12-19 | 2016-11-24 | Amplimmune, Inc. | Anti-human B7-H4 antibodies and their uses |
| EP3760719A1 (en) | 2013-11-18 | 2021-01-06 | CRISPR Therapeutics AG | Crispr-cas system materials and methods |
| JP6476182B2 (ja) | 2013-11-22 | 2019-02-27 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ | 改変された高親和性ヒトt細胞受容体 |
| EP3177314B1 (en) | 2014-08-04 | 2020-10-07 | Fred Hutchinson Cancer Research Center | T cell immunotherapy specific for wt-1 |
| TW201625689A (zh) | 2014-09-12 | 2016-07-16 | 建南德克公司 | 抗-b7-h4抗體及免疫結合物 |
| RU2017115315A (ru) | 2014-10-03 | 2018-11-08 | Дана-Фарбер Кэнсер Инститьют, Инк. | Антитела к рецептору глюкокортикоид-индуцированного фактора некроза опухоли (gitr) и способы их применения |
| IL254039B2 (en) | 2015-02-19 | 2023-12-01 | Compugen Ltd | Anti-pvrig antibodies and methods of use |
| SG11201707182WA (en) | 2015-03-05 | 2017-10-30 | Hutchinson Fred Cancer Res | Immunomodulatory fusion proteins and uses thereof |
| JO3620B1 (ar) | 2015-08-05 | 2020-08-27 | Amgen Res Munich Gmbh | مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم |
| US11047011B2 (en) | 2015-09-29 | 2021-06-29 | iRepertoire, Inc. | Immunorepertoire normality assessment method and its use |
| WO2017112944A1 (en) * | 2015-12-23 | 2017-06-29 | Fred Hutchinson Cancer Research Center | High affinity t cell receptors and uses thereof |
| AU2017232431A1 (en) | 2016-03-15 | 2018-09-20 | Cancer Research Technology Limited | Chimeric antigen receptor |
| KR102397771B1 (ko) | 2016-09-23 | 2022-05-13 | 프레드 헛친슨 켄서 리서치 센터 | 부 조직적합성(h) 항원 ha-1에 대해서 특이적인 tcr 및 이의 용도 |
| EA201992536A1 (ru) * | 2017-04-24 | 2020-03-05 | Оспедале Сан Раффаэле С.Р.Л. | Tcr и пептиды |
| PL3765615T3 (pl) | 2018-03-14 | 2023-11-13 | Arbor Biotechnologies, Inc. | Nowe enzymy i układy crispr ukierunkowane na dna |
-
2020
- 2020-03-10 BR BR112021017703A patent/BR112021017703A8/pt unknown
- 2020-03-10 KR KR1020217032466A patent/KR20210138043A/ko not_active Ceased
- 2020-03-10 CN CN202080033281.4A patent/CN113784978B/zh active Active
- 2020-03-10 SG SG11202109745P patent/SG11202109745PA/en unknown
- 2020-03-10 US US17/438,380 patent/US12448430B2/en active Active
- 2020-03-10 EA EA202192252A patent/EA202192252A1/ru unknown
- 2020-03-10 MX MX2021010837A patent/MX2021010837A/es unknown
- 2020-03-10 CA CA3132845A patent/CA3132845A1/en active Pending
- 2020-03-10 AU AU2020237043A patent/AU2020237043A1/en not_active Abandoned
- 2020-03-10 EP EP20716656.2A patent/EP3938386A1/en active Pending
- 2020-03-10 JP JP2021554674A patent/JP7611844B2/ja active Active
- 2020-03-10 WO PCT/US2020/021916 patent/WO2020185796A1/en not_active Ceased
-
2021
- 2021-09-09 IL IL286202A patent/IL286202A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024074801A5 (cg-RX-API-DMAC7.html) | ||
| Houot et al. | T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition | |
| JP2017523784A5 (cg-RX-API-DMAC7.html) | ||
| Criscitiello | Tumor-associated antigens in breast cancer | |
| Rosenberg | Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens | |
| JP7577252B2 (ja) | CD300cの発現抑制剤または活性抑制剤を含む癌の予防または治療用薬学的組成物 | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| JP2022537700A5 (cg-RX-API-DMAC7.html) | ||
| Zhang et al. | Genetic engineering with T cell receptors | |
| CN113056283A (zh) | 关于治疗血液肿瘤的工程化和非工程化γδ-T细胞的组合物和方法 | |
| Franks et al. | New anticancer immunotherapies | |
| CN114555815B (zh) | T细胞受体及其使用方法 | |
| JP2023542528A5 (cg-RX-API-DMAC7.html) | ||
| JP2022547809A5 (cg-RX-API-DMAC7.html) | ||
| CN114450414B (zh) | T细胞受体及其使用方法 | |
| JP2022506781A5 (cg-RX-API-DMAC7.html) | ||
| JP2024528029A5 (cg-RX-API-DMAC7.html) | ||
| TWI785426B (zh) | 包含含有il-2蛋白及cd80蛋白之融合蛋白與自然殺手細胞的用於治療癌症的藥學組成物 | |
| AU2012281131B2 (en) | Novel zinc finger-like peptide compositions as potent agents in cancer prevention and treatment | |
| Madany et al. | Immunobiology and immunotherapeutic targeting of glioma stem cells | |
| Smith et al. | Immunotherapy of colorectal cancer | |
| JP2023526416A5 (cg-RX-API-DMAC7.html) | ||
| Subklewe | Current status of immunotherapy in acute myeloid leukemia | |
| US20180028630A1 (en) | Compositions and methods for therapeutic anti-cancer vaccination | |
| WO2026082164A1 (en) | A modified dual-targeting t cell receptor complex and its pharmaceutical application thereof |